March 18, 2018

Biosimilar treatment for certain breast and stomach cancers approved by FDA

05 December 2017, 02:17 | Lena Norman

Mylan and Biocon are among a host of biosim developers that are working to grab a piece of Roche’s global cancer fortunes

Mylan and Biocon are among a host of biosim developers that are working to grab a piece of Roche’s global cancer fortunes

Mylan anticipates potentially being the first company to offer a biosimilar to Herceptin, as a result of its ability to secure global licenses for its trastuzumab product from Genentech and Roche earlier this year.

Mylan has become the first pharma company to win U.S. approval for a biosimilar of Roche's big-selling cancer antibody Herceptin.

Amgen/Allergan, Pfizer, and Samsung Bioepsis are also developing biosimilar Herceptin products for the USA and worldwide markets, but analysts have suggested that Roche's brand will not see a dramatic reduction in sales after the rivals launch, in part because use of the drug in combination with newer HER2 drug Perjeta (pertuzumab) is on the rise.

The US Food and Drug Administration (FDA) on Friday approved Mylan N.V. and Biocon Ltd's biosimilar for Roche's drug Herceptin, used in the treatment of breast and metastatic stomach cancer. Raises $12 Million from Bill Gates and Other Backers
Several cities - including Austin, Boston, Houston and Los Angeles - said they would offer classes in every high school. Founded in 2013 by twin brothers Hadi and Ali Partovi, has found many backers in Silicon Valley.

Ogivri is already approved in 19 countries around the world, and Mylan and Biocon are now working with regulatory authorities in Australia, Canada, and Europe for approval for the Herceptin biosimilar. Ogivri has been approved as a biosimilar, not as an interchangeable product, the regulator said. "We now look forward to moving ahead with the rest of the regulatory review process in Europe and to bringing these important treatment options to cancer patients". "We are proud to receive FDA approval of Ogivri".

"We are extremely pleased with the acceptance of our [marketing authorization application in Europe]", Rajiv Malik, Mylan's president, said in a press release. It strengthens our resolve to focus on developing affordable biologics that can make cancer care both more effective and more equitable around the world.

"Biocon and Mylan have a shared commitment to enhance access to cutting-edge bio-therapeutics and this approval will enable us to provide an affordable alternative for cancer care that will address the unmet needs of patients in the USA", Biocon CMD Kiran Mazumdar-Shaw said. Dr Arun Chandavarkar, CEO & Joint MD, Biocon, added that the approval represents a landmark achievement for the Biocon-Mylan collaboration and is an important endorsement of our development and manufacturing capabilities in the area of monoclonal antibodies. It is approved in 19 countries, including India.

Other News

Trending Now

Pink Raising Her Children to Be Gender-Neutral
That being said , we have learned that Pink has been raising her offspring in a " gender neutral " household. They say I look like a boy or I'm too masculine or I have too many opinions, my body is too strong'.

Rolling Out with Credit Changes - Electronic Arts
This is an area we agree needed to be buffed a bit, especially when it comes to rewarding players for doing well in-game. Well an update has been announced today to shorten the long grind.

Shaun Livingston ejected after making contact with an official
After getting tossed from the game, Livingston untucked his white jersey as he walked off the court. So, you could tell that things were a little heated right there.

Supreme Court won't review Texas decision against same-sex benefits
However, the court has said on several occasions that the denial of such petitions "without more has no significance as a ruling". Supreme Court ruled 6-3 against an Arkansas law forbidding same-sex couples from being listed on a child's birth certificate.

Zlatan Ibrahimovic still suffering effects of long-term knee injury, says Jose Mourinho
Selected tomorrow - yes for sure. "He is selected for tomorrow for start or be on the bench, I can not answer". To work really hard for a certain period of time he can not play for theses days, so we decide to do that".

Bryan Singer fired from Freddie Mercury biopic
He is believed to have been in the States for roughly the last ten days while the cast and crew have been in London. It was also due in part to Singer's "unexpected unavailability" that was announced over the weekend.

Santa Clarita Weather: High Winds, Red Flag Warning Issued This Week
The county will also augmenting staffing and position more engine companies in strategic areas throughout the county. In addition, there is the potential for blowing dust and debris, especially near recent burn areas.

Google giving 6 months of free Netflix with select Chromebooks
Google is at it again with some exclusive goodies for owners of the Pixelbook or Samsung Chromebooks Pro and Plus. Google's own Pixelbook is included, while the Samsung Chromebook Plus and Chromebook Pro models are also eligible.

Texas A&M to announce Jimbo Fisher as new football coach
Florida State coach Jimbo Fisher recaps his team's final practice before its season finale against Louisiana Monroe on Saturday. Woodward fired Kevin Sumlin after six seasons at Texas A&M, leading the Aggies to a 51-26 record during his tenure.

Your Guide to Following the US Tax-Cut Debate: QuickTake Q&A
In another change, the alternative minimum tax (AMT), both for individuals and corporations, would not be repealed in full. No Democrats voted for the bill, but they were unable to block it because Republicans hold a 52-48 Senate majority.